Literature DB >> 9374650

Intermediate endocrine-acinar pancreatic cells in duct ligation conditions.

E Bertelli1, M Bendayan.   

Abstract

When tissues were subjected to 24 h of duct ligation, intermediate pancreatic cells simultaneously displaying endocrine and exocrine phenotypes appeared. Immunocytochemistry by laser scanning confocal microscopy revealed the appearance of a large number of these cells coexpressing insulin and amylase. These cells were located within the islets of Langerhans as well as in the acinar parenchyma. They were also detected in a culture system of isolated pancreatic cells. With the use of immunoelectron microscopy, two types of secretory granules were identified in these cells. One was insulin immunoreactive, whereas the other, resembling zymogen granules, contained amylase. Occasionally, some small granules displayed a double labeling for both secretory proteins. Numerous crinophagic bodies and autophagosomes containing insulin and/or amylase were also present. In situ hybridization, applied with the specific probes, confirmed the presence of both insulin and amylase mRNAs in these cells. Because duct ligation is known to induce insulin cell proliferation, the present results confirm that endocrine-acinar cells do appear in such condition and may represent intermediate steps in a transdifferentiating process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374650     DOI: 10.1152/ajpcell.1997.273.5.C1641

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  Evidence for epithelial-mesenchymal transition in adult human pancreatic exocrine cells.

Authors:  Marjorie Fanjul; Valéry Gmyr; Coralie Sengenès; Ginette Ratovo; Marlène Dufresne; Bruno Lefebvre; Julie Kerr-Conte; Etienne Hollande
Journal:  J Histochem Cytochem       Date:  2010-06-07       Impact factor: 2.479

2.  In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells.

Authors:  L Baeyens; S De Breuck; J Lardon; J K Mfopou; I Rooman; L Bouwens
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

Review 3.  beta-cell Regeneration: neogenesis, replication or both?

Authors:  Fred Levine; Pamela Itkin-Ansari
Journal:  J Mol Med (Berl)       Date:  2007-10-06       Impact factor: 4.599

Review 4.  Transdifferentiation of pancreatic α-cells into insulin-secreting cells: From experimental models to underlying mechanisms.

Authors:  Jieli Lu; Rami Jaafer; Rémy Bonnavion; Philippe Bertolino; Chang-Xian Zhang
Journal:  World J Diabetes       Date:  2014-12-15

Review 5.  Concise review: pancreas regeneration: recent advances and perspectives.

Authors:  Philippe A Lysy; Gordon C Weir; Susan Bonner-Weir
Journal:  Stem Cells Transl Med       Date:  2012-01-26       Impact factor: 6.940

6.  Spatiotemporal patterns of multipotentiality in Ptf1a-expressing cells during pancreas organogenesis and injury-induced facultative restoration.

Authors:  Fong Cheng Pan; Eric D Bankaitis; Daniel Boyer; Xiaobo Xu; Mark Van de Casteele; Mark A Magnuson; Harry Heimberg; Christopher V E Wright
Journal:  Development       Date:  2013-01-16       Impact factor: 6.868

Review 7.  Cellular origins of beta-cell regeneration: a legacy view of historical controversies.

Authors:  A Granger; J A Kushner
Journal:  J Intern Med       Date:  2009-10       Impact factor: 8.989

Review 8.  Making β cells from adult cells within the pancreas.

Authors:  Philippe A Lysy; Gordon C Weir; Susan Bonner-Weir
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

9.  TCF7L2 promotes beta cell regeneration in human and mouse pancreas.

Authors:  L Shu; K Zien; G Gutjahr; J Oberholzer; F Pattou; J Kerr-Conte; K Maedler
Journal:  Diabetologia       Date:  2012-09-04       Impact factor: 10.122

10.  Dicer is required for maintaining adult pancreas.

Authors:  Sumiyo Morita; Akemi Hara; Itaru Kojima; Takuro Horii; Mika Kimura; Tadahiro Kitamura; Takahiro Ochiya; Katsumi Nakanishi; Ryo Matoba; Kenichi Matsubara; Izuho Hatada
Journal:  PLoS One       Date:  2009-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.